Cargando…
Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response
The incidence of heart failure (HF) continues to increase rapidly in patients with diabetes. It is marked by myocardial remodeling, including fibrosis, hypertrophy, and cell death, leading to diastolic dysfunction with or without systolic dysfunction. Diabetic cardiomyopathy (DCM) is a distinct myoc...
Autores principales: | Kaur, Namrita, Guan, Yingshu, Raja, Rida, Ruiz-Velasco, Andrea, Liu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257042/ https://www.ncbi.nlm.nih.gov/pubmed/34234695 http://dx.doi.org/10.3389/fphys.2021.694864 |
Ejemplares similares
-
Cellular Protein Quality Control in Diabetic Cardiomyopathy: From Bench to Bedside
por: Kaur, Namrita, et al.
Publicado: (2020) -
Paracrine signal emanating from stressed cardiomyocytes aggravates inflammatory microenvironment in diabetic cardiomyopathy
por: Kaur, Namrita, et al.
Publicado: (2022) -
The multifaceted roles of ER and Golgi in metabolic cardiomyopathy
por: Raja, Rida, et al.
Publicado: (2022) -
Novel Insights Into Molecular Mechanism of Mitochondria in Diabetic Cardiomyopathy
por: Bai, Jing, et al.
Publicado: (2021) -
Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications
por: Chen, Gong, et al.
Publicado: (2018)